aTyr Pharma Inc. (NASDAQ:LIFE) price closed higher on Monday, September 13, jumping 66.97% above its previous close.
A look at the daily price movement shows that the last close reads $5.48, with intraday deals fluctuated between $5.84 and $9.29. The company’s 5Y monthly beta was ticking 2.00. Taking into account the 52-week price action we note that the stock hit a 52-week high of $8.33 and 52-week low of $2.93. The stock added 85.98% on its value in the past month.
aTyr Pharma Inc., which has a market valuation of $156.83 million, is expected to release its quarterly earnings report Nov 10, 2021 – Nov 15, 2021. Analysts tracking LIFE have forecast the quarterly EPS to shrink by -0.59 per share this quarter, while the same analysts predict the annual EPS to hit -$2.19 for the year 2021 and up to -$2.15 for 2022. In this case, analysts estimate an annual EPS growth of -23.70% for the year and 1.80% for the next year.
Staying with the analyst view, there is a consensus estimate of $3 million for the company’s annual revenue in 2021. Per this projection, the revenue is forecast to grow -71.30% below that which the company brought in 2021.
Revisions to the company’s EPS highlights a short term direction of a stock’s price movement, which in the last 7 days came up with no upward and no downward reviews. On the technical perspective front, indicators give LIFE a short term outlook of 100% Buy on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Buy, while an average of long term indicators are currently assigning the stock as 100% Buy.
The overview shows that LIFE’s price is at present 77.76% off the SMA20 and 89.43% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 90.72, with weekly volatility standing at 15.18%. The indicator jumps to 6.94% when calculated based on the past 30 days. aTyr Pharma Inc. (NASDAQ:LIFE)’s beta value is holding at 2.01, while the average true range (ATR) indicator is currently reading 0.46.
An analysis of the aTyr Pharma Inc. (NASDAQ:LIFE) stock in terms of its daily trading volume indicates that the 3-month average is 182.96K. However, this figure increases on the past 10-day timeline to an average of 0.14 million.
Current records show that the company has 16.13M in outstanding shares. The insiders’ percentage holdings are 0.30% of outstanding shares while the percentage share held by institutions stands at 49.20%. The stats also highlight that short interest as of Aug 12, 2021, stood at 0.55 million shares, which puts the short ratio at the time at 2.73. From this we can glean that short interest is 3.23% of company’s current outstanding shares. Notably, we see that shares short in August fall slightly given the previous month’s figure stood at 0.62 million. But the 135.82% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.